S&P 500 ETF jumps 2% after hours on report Gilead drug showing effectiveness treating coronavirus The ETF that tracks the S&P 500 rallied in after-hours trading Thursday after a report said a Gilead Sciences drug was showing effectiveness in treating the coronavirus. The move pointed to a jump for the stock market on Friday. Around 5 p.m. ET, the SPDR S&P 500 ETF Trust (SPY) was up 2%. Stock futures open at 6 p.m. ET. Gilead shares jumped by 9% after STAT news reported that a Chicago hospital treating coronavirus patients with Remdesivir in a trial were recovering rapidly from severe symptoms. The publication cited a video it obtained where the trial results were discussed. Stocks tumbled from record highs in February into a bear market a month later as the spread of the coronavirus roiled market sentiment and the economic outlook.
The ETF that tracks the S&P 500 rallied in after-hours trading Thursday after a report said a Gilead Sciences drug was showing effectiveness in treating the coronavirus. The move pointed to a jump for the stock market on Friday.
Around 5 p.m. ET, the SPDR S&P 500 ETF Trust (SPY) was up 2%. Stock futures open at 6 p.m. ET.
Gilead shares jumped by 9% after STAT news reported that a Chicago hospital treating coronavirus patients with Remdesivir in a trial were recovering rapidly from severe symptoms. The publication cited a video it obtained where the trial results were discussed.
Stocks tumbled from record highs in February into a bear market a month later as the spread of the coronavirus roiled market sentiment and the economic outlook.
licensing 给其他药厂把。
那是要配合大统领一会的发言。。。。
我觉得是某国一直在刻意压制人民的希望的作用，特别是在当年的大形势下
那么多病人，最后却说病人人数不够，所以实验就不做了。这听着就不象是科学的态度，而是政治上的需要
全世界7个目前进行的实验呢，又不是只有中国一个。要是这个要真特效，那么其他六个都会证明有特效，中国咋折腾也没用啊。那么多病人，也得病人愿意啊。没人愿意你难道逼人家？
第一次有美国医院官方证实有效，美国的官僚们不相信美国之外的数据。
怎么可能先price in呢？而且就算price in那也是内行人搞生物医药投资这一块的trader做的，广大散户跟进还早呢。但是即使现在这种状态也是要小心，万一后面有不好消息可能会跌